Mannitol/sorbitol topical Interactions
There are 137 drugs known to interact with mannitol/sorbitol topical, along with 7 disease interactions. Of the total drug interactions, 13 are major, 122 are moderate, and 2 are minor.
Medications known to interact with mannitol/sorbitol topical
Note: Showing generic names only.
A
B
C
- canagliflozin
- captopril
- carbamazepine
- casanthranol
- cascara sagrada
- castor oil
- cisatracurium
- citalopram
D
- dapagliflozin
- demeclocycline
- desvenlafaxine
- diatrizoate
- digitoxin
- digoxin
- dimethyl fumarate
- diroximel fumarate
- doxycycline
- droperidol
- duloxetine
E
- empagliflozin
- enalapril
- enalaprilat
- epoprostenol
- eravacycline
- ertugliflozin
- escitalopram
- eslicarbazepine
- exenatide
F
G
H
I
- iloprost
- indacaterol
- iodamide
- iodipamide
- iodixanol
- iohexol
- iomeprol
- iopamidol
- iopromide
- iothalamate
- ioversol
- ioxaglate
- ioxilan
- irinotecan
- irinotecan liposomal
- isoetharine
K
L
M
- magnesium citrate
- magnesium hydroxide
- maraviroc
- metaproterenol
- metrizamide
- milnacipran
- mineral oil
- minocycline
- mivacurium
- mixed grass pollens allergen extract
- moexipril
- monomethyl fumarate
N
O
P
- pancuronium
- paroxetine
- peanut allergen powder
- pentoxifylline
- perindopril
- phenolphthalein
- pirbuterol
- plazomicin
- polyethylene glycol 3350
- polyethylene glycol 3350 with electrolytes
Q
R
S
- salmeterol
- selexipag
- senna
- sertraline
- sibutramine
- sodium nitrite
- sodium polystyrene sulfonate
- sotagliflozin
- sparsentan
- streptomycin
- succinylcholine
T
- taurine
- terbutaline
- tetracycline
- tigecycline
- timothy grass pollen allergen extract
- tobramycin
- trandolapril
- treprostinil
V
Mannitol/sorbitol topical disease interactions
There are 7 disease interactions with mannitol / sorbitol topical which include:
- inflammatory bowel disease
- intestinal obstruction disorders
- fluid overload
- fluid expansion
- hyperosmolar effects
- diabetes
- sodium imbalances
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.